Alpha Teknova, Inc. (TKNO)
USD 4.64
(2.88%)
USD 4.64
(2.88%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 13.25 Million USD | -66.94% |
| 2022 | 40.08 Million USD | 237.72% |
| 2021 | 11.87 Million USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 12.27 Million USD | -6.88% |
| 2024 Q1 | 13.17 Million USD | -0.55% |
| 2023 Q1 | 38.9 Million USD | -2.94% |
| 2023 Q3 | 29.04 Million USD | 77.93% |
| 2023 FY | 13.25 Million USD | -66.94% |
| 2023 Q2 | 16.32 Million USD | -58.05% |
| 2023 Q4 | 13.25 Million USD | -54.37% |
| 2022 Q3 | 33.7 Million USD | -1.52% |
| 2022 FY | 40.08 Million USD | 237.72% |
| 2022 Q4 | 40.08 Million USD | 18.92% |
| 2022 Q2 | 34.22 Million USD | 14.65% |
| 2022 Q1 | 29.85 Million USD | 151.51% |
| 2021 FY | 11.87 Million USD | 0.0% |
| 2021 Q3 | 11.82 Million USD | 0.37% |
| 2021 Q2 | 11.78 Million USD | 0.39% |
| 2021 Q1 | 11.73 Million USD | 0.0% |
| 2021 Q4 | 11.87 Million USD | 0.37% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Journey Medical Corporation | 14.62 Million USD | 9.376% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 95.721% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 85.451% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 97.421% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -2358.282% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -2358.282% |
| SCYNEXIS, Inc. | 12.15 Million USD | -8.981% |
| Safety Shot Inc | 304.9 Thousand USD | -4245.915% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 97.296% |
| Bright Green Corporation | 201.78 Thousand USD | -6466.956% |
| Dynavax Technologies Corporation | 252.41 Million USD | 94.75% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 97.358% |
| Cosmos Health Inc. | 3.03 Million USD | -336.557% |
| PainReform Ltd. | 30 Thousand USD | -44070.0% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -11213.168% |
| Embecta Corp. | 1.62 Billion USD | 99.185% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 0.563% |
| Procaps Group, S.A. | 28.41 Million USD | 53.358% |
| Theratechnologies Inc. | 51.26 Million USD | 74.15% |
| Harrow Health, Inc. | 183.17 Million USD | 92.766% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -15131.034% |
| Biofrontera Inc. | 804 Thousand USD | -1548.134% |
| DURECT Corporation | 2.7 Million USD | -390.415% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 60.083% |
| Cronos Group Inc. | 1.55 Million USD | -749.968% |
| OptiNose, Inc. | 611 Thousand USD | -2068.74% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 97.341% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 61.243% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -2812.308% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 78.186% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | -3.652% |
| Radius Health, Inc. | 339.66 Million USD | 96.099% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | -29.177% |
| Phibro Animal Health Corporation | 458.28 Million USD | 97.109% |
| Procaps Group S.A. | 28.41 Million USD | 53.358% |
| Alvotech | 1.02 Billion USD | 98.711% |
| TherapeuticsMD, Inc. | 6.53 Million USD | -102.863% |
| Viatris Inc. | 16.18 Billion USD | 99.918% |
| Rockwell Medical, Inc. | 8.29 Million USD | -59.785% |
| Aytu BioPharma, Inc. | 10.87 Million USD | -21.826% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -3843.856% |
| Tilray Brands, Inc. | 287.93 Million USD | 95.398% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 89.004% |
| Shineco, Inc. | 10.01 Million USD | -32.281% |
| PetIQ, Inc. | 437.82 Million USD | 96.973% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -6210.0% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 94.87% |
| Alimera Sciences, Inc. | 64.48 Million USD | 79.452% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 65.594% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -9709.089% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | -93.238% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -1740.417% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -58835.243% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 59.551% |
| Hempacco Co., Inc. | 5.93 Million USD | -123.419% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 98.711% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 76.428% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 97.849% |
| Currenc Group, Inc. | 2.5 Million USD | -428.566% |
| Kamada Ltd. | 7.43 Million USD | -78.153% |
| Indivior PLC | 235.66 Million USD | 94.377% |
| Evoke Pharma, Inc. | 5 Million USD | -165.02% |
| Flora Growth Corp. | 942 Thousand USD | -1306.688% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -58835.243% |
| Evolus, Inc. | 120.35 Million USD | 88.99% |
| HUTCHMED (China) Limited | 48.18 Million USD | 72.502% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 97.751% |
| Akanda Corp. | 2.49 Million USD | -430.644% |